Erschienen in:
15.06.2018 | T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor)
Pathogenesis of Enteropathy-Associated T Cell Lymphoma
verfasst von:
Udit Chander, Rebecca J. Leeman-Neill, Govind Bhagat
Erschienen in:
Current Hematologic Malignancy Reports
|
Ausgabe 4/2018
Einloggen, um Zugang zu erhalten
Abstract
Purpose of Review
To provide an update on the pathogenesis of enteropathy-associated T cell lymphoma (EATL) and its relationship with refractory celiac disease (RCD), in light of current knowledge of immune, genetic, and environmental factors that promote neoplastic transformation of intraepithelial lymphocytes (IELs).
Recent Findings
EATL frequently evolves from RCD type II (RCD II) but can occur “de novo” in individuals with celiac disease. Recurrent activating mutations in members of the JAK/STAT pathway have been recently described in EATL and RCD II, which suggests deregulation of cytokine signaling to be an early event in lymphomagenesis. Intraepithelial T cells are presumed to be the cell of origin of EATL (and RCD II). Recent in vitro molecular and phenotypic analyses and in vivo murine studies, however, suggest an origin of RCD II from innate IELs (NK/T cell precursors), which could also be the cell of origin of RCD II-derived EATL.
Summary
The immune microenvironment of the small intestinal mucosa in celiac disease fosters the development of EATL, often in a multistep pathway.